December 6, 2018 / 2:39 PM / 7 days ago

BRIEF-Adamis Pharmaceuticals Provides Update On Symjepi's U.S. Launch

Dec 6 (Reuters) - Adamis Pharmaceuticals Corp:

* ADAMIS PHARMACEUTICALS PROVIDES UPDATE ON THE U.S. LAUNCH OF SYMJEPI

* ADAMIS PHARMACEUTICALS - PROVIDED BUSINESS UPDATE ANNOUNCING U.S. LAUNCH OF FDA-APPROVED SYMJEPI 0.3MG INJECTION IS PLANNED FOR EARLY Q1 2019.

* ADAMIS PHARMACEUTICALS - MANUFACTURE OF COMMERCIAL BATCHES COMPLETED, ADAMIS WILL BEGIN SHIPPING TO SANDOZ DISTRIBUTION CENTERS DURING DEC Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below